<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ETM</journal-id>
<journal-title-group>
<journal-title>Experimental and Therapeutic Medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">1792-0981</issn>
<issn pub-type="epub">1792-1015</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/etm.2016.3796</article-id>
<article-id pub-id-type="publisher-id">ETM-0-0-3796</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Toll-like receptor 4 gene is associated with recurrent spontaneous miscarriage in Uygur and Han women in Xinjiang</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Jiao</surname><given-names>Yonghui</given-names></name>
<xref rid="af1-etm-0-0-3796" ref-type="aff">1</xref>
<xref rid="af2-etm-0-0-3796" ref-type="aff">2</xref>
<xref rid="af3-etm-0-0-3796" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Jing</given-names></name>
<xref rid="af3-etm-0-0-3796" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author"><name><surname>Hu</surname><given-names>Bo</given-names></name>
<xref rid="af3-etm-0-0-3796" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author"><name><surname>La</surname><given-names>Xiaoling</given-names></name>
<xref rid="af3-etm-0-0-3796" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author"><name><surname>Gong</surname><given-names>Xiaoyun</given-names></name>
<xref rid="af3-etm-0-0-3796" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author"><name><surname>Huang</surname><given-names>Ying</given-names></name>
<xref rid="af2-etm-0-0-3796" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author"><name><surname>Cai</surname><given-names>Xia</given-names></name>
<xref rid="af3-etm-0-0-3796" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Yi</given-names></name>
<xref rid="af1-etm-0-0-3796" ref-type="aff">1</xref>
<xref rid="c1-etm-0-0-3796" ref-type="corresp"/></contrib>
</contrib-group>
<aff id="af1-etm-0-0-3796"><label>1</label>Department of Gynecology and Obstetrics, Xiang Ya Hospital, Central South University, Changsha, Hunan 410008, P.R. China</aff>
<aff id="af2-etm-0-0-3796"><label>2</label>Department of Obstetrics, People&#x0027;s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang 830001, P.R. China</aff>
<aff id="af3-etm-0-0-3796"><label>3</label>Reproductive Medical Center, First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830054, P.R. China</aff>
<author-notes>
<corresp id="c1-etm-0-0-3796"><italic>Correspondence to</italic>: Dr Yi Zhang, Department of Gynecology and Obstetrics, Xiang Ya Hospital, Central South University, 87 Xiang-Ya-Road, Changsha, Hunan 410008, P.R. China, E-mail: <email>yizhang3810@126.com</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>11</month>
<year>2016</year></pub-date>
<pub-date pub-type="epub">
<day>11</day>
<month>10</month>
<year>2016</year></pub-date>
<volume>12</volume>
<issue>5</issue>
<fpage>3268</fpage>
<lpage>3274</lpage>
<history>
<date date-type="received"><day>23</day><month>03</month><year>2015</year></date>
<date date-type="accepted"><day>11</day><month>08</month><year>2016</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x00A9; Jiao et al.</copyright-statement>
<copyright-year>2016</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license>
</permissions>
<abstract>
<p>Toll-like receptor 4 (TLR4), a recently identified vertebrate receptor, serves a pivotal role in immune responses. The aim of the present study was to investigate the association between the human <italic>TLR4</italic> gene and recurrent spontaneous miscarriage (RSM). A total of 306 RSM patents and 306 age-matched controls were genotyped for four single-nucleotide polymorphisms (SNPs) of the human <italic>TLR4</italic> gene (rs1927914, rs1927911, rs4986790 and rs4986791). Data were analyzed for Uygur and Han women separately using a haplotype-based case-control study. There were significant differences between the distributions of rs1927914, rs1927911 and rs4986790 SNPs between RSM patients and the controls (P=0.001, P&#x003C;0.001 and P=0.015, respectively) were identified in Uygur women, and significant differences between the distributions of the rs1927914 and rs1927911 SNPs between RSM patients and the controls (P&#x003C;0.001 and P&#x003C;0.001, respectively) were identified in Han women. Results of the logistic regression analysis indicated that rs1927914, rs1927911 and rs4986790 SNPs were significantly higher in the RSM patients compared with the control individuals (P=0.012, P=0.024 and P=0.035, respectively) in Uygur women. Furthermore, significantly higher frequency was noted for the A-G-G haplotype (SNP1-SNP2-SNP3) (P=0.016) in RSM patients compared with the controls in Uygur women. The results indicate that rs1927914, rs1927911, rs4986790 and the A-G-G haplotype (SNP1-SNP2-SNP3) of the human TLR4 gene may be genetic markers for RSM in Uygur women, while rs1927914 and rs1927911 SNPs of the human <italic>TLR4</italic> gene are most likely associated with RSM in Han women in Xinjiang.</p>
</abstract>
<kwd-group>
<kwd><italic>TLR4</italic></kwd>
<kwd>recurrent spontaneous miscarriage</kwd>
<kwd>single-nucleotide polymorphism</kwd>
<kwd>case-control study</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Recurrent spontaneous miscarriage (RSM), defined as three or more consecutive losses before 20 weeks of gestation with the same partner (<xref rid="b1-etm-0-0-3796" ref-type="bibr">1</xref>), comprise a multifactorial condition enhanced by a variety of genetic, endocrine, anatomic, immunological, infectious, environmental, thrombophilic and metabolic factors (<xref rid="b2-etm-0-0-3796" ref-type="bibr">2</xref>). Regardless of extensive research undertaken in this field, the underlying cause of the majority (&#x2264;50&#x0025;) of RSM cases remains unknown and hence poses a clinical challenge (<xref rid="b3-etm-0-0-3796" ref-type="bibr">3</xref>).</p>
<p>Toll-like receptors (TLRs), a recently identified group of vertebrate receptors, serve a pivotal role in immune responses. There are 10 TLRs expressed in humans (<xref rid="b4-etm-0-0-3796" ref-type="bibr">4</xref>), and Toll-like receptor 4 (TLR4) is one of the most actively investigated TLRs. TLR4 serves an essential role in the activation and regulation of the innate and acquired immune responses through the recognition of specific molecular patterns of pathogens and endogenous peptides (<xref rid="b5-etm-0-0-3796" ref-type="bibr">5</xref>).</p>
<p>Single-nucleotide polymorphisms (SNPs) are present in a number of TLR genes and have been implicated in the loss of self-tolerance, which may lead to autoimmunity and chronic inflammation (<xref rid="b6-etm-0-0-3796" ref-type="bibr">6</xref>). A number of studies have suggested that <italic>TLR4</italic> polymorphisms are associated with the development of chronic inflammatory conditions (<xref rid="b7-etm-0-0-3796" ref-type="bibr">7</xref>,<xref rid="b8-etm-0-0-3796" ref-type="bibr">8</xref>), chronic granulomatous conditions (<xref rid="b9-etm-0-0-3796" ref-type="bibr">9</xref>) and cardivascular diseases (<xref rid="b10-etm-0-0-3796" ref-type="bibr">10</xref>).</p>
<p>To the best of our knowledge, there have been no previous studies on the association between the human <italic>TLR4</italic> gene and RSM in Uygur women in Xinjiang. The aim of the present study was to investigate the association between the human <italic>TLR4</italic> gene and RSM using a haplotype-based case-control study that employed SNPs in conjunction with separate analyses that examined the data with regard to Uygur and Han women.</p>
</sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title/>
<sec>
<title>Subjects</title>
<p>Subjects diagnosed with RSM were recruited at the First Affiliated Hospital of Xinjiang Medical University in Urumqi, China, between 2012 and 2014. A total of 306 RSM patients were enrolled in the present study, with a Uygur/Han ratio of 1.01. RSM was diagnosed based on the following criteria: Patients who had experienced the spontaneous loss of three or more consecutive pregnancies prior to 20 weeks of gestation were included in the RSM group. Patients diagnosed with chromosomal abnormalities, uterine abnormalities, hereditary thrombophilia, endocrinologic disorders, immunologic factors and infections were excluded. A total of 306 age-matched healthy individuals (Uygur/Han ratio, 1.03) were enrolled as controls. There was no history of abortions or fertility treatments and no normal menstrual cycles for the controls. Informed consent was obtained from each of the subjects in accordance with the protocol approved by the Human Studies Committee of Xingjiang Medical University.</p>
</sec>
<sec>
<title>Genotyping</title>
<p>The human <italic>TLR4</italic> gene is located on chromosome 9q33.1, spans ~17 kilobase pairs and contains four exons. There are 920 SNPs for the human <italic>TLR4</italic> gene listed in the National Center for Biotechnology Information SNP database Build 130 (<uri xlink:href="http://www.ncbi.nlm.nih.gov/SNP">http://www.ncbi.nlm.nih.gov/SNP</uri>). Data for tag SNPs was screened using the International HapMap Project (<uri xlink:href="http://www.hapmap.org/index.html.ja">http://www.hapmap.org/index.html.ja</uri>) using a cutoff level of r<sup>2</sup> &#x2265;0.5. According to the above criteria, rs1927914 (SNP1), rs1927911 (SNP2), rs4986790 (SNP3) and rs4986791 (SNP4) were selected for the present study. The structure of the human <italic>TLR4</italic> gene is presented in <xref rid="f1-etm-0-0-3796" ref-type="fig">Fig. 1</xref>.</p>
<p>Blood samples were collected from each participant and genomic DNA was extracted from peripheral blood leukocytes by phenol and chloroform extraction. DNA sequencing using the Sanger dideoxy method was performed by Polymorphic DNA Technologies (Alameda, CA, USA). The four SNPs that were used for complete sequencing of the <italic>TLR4</italic> region included a portion of the upstream region, introns and exons, and these were analyzed in patients and controls from the cohort. Sequencing reactions were performed by O&#x0026;E High-Tech Corporation in Beijing, China, and sequencing primers were designed using Primer Premier 5.0 software (Palo Alto, CA, USA).</p>
</sec>
<sec>
<title>Genotyping of novel SNPs</title>
<p>The detailed of genotyping of novel SNP have been previously described (<xref rid="b11-etm-0-0-3796" ref-type="bibr">11</xref>). Briefly, DNA sequencing of the complete <italic>TLR4</italic> region was performed using a polymerase chain reaction direct sequencing method, which identified a heterozygous variant in subjects with RSM and controls. The sense primer for SNP1 was 5&#x2032;TAGCATGAGAAATGAGGAAGTAAGGG3&#x2032; and the antisense primer was 5&#x2032;GAGCTATGATGAGGATTGAAAATGTGG3&#x2032;. The sense primer for SNP2 was 5&#x2032;TAGCTGGCTTCTGCAAGGAAT3&#x2032; and the antisense primer was 5&#x2032;GGAGACTGTCTGGCAGTCAAGATGT3&#x2032;. The sense primer for SNP3 was 5&#x2032;GTCCCTGAACCCTATGAACTTTATCC3&#x2032; and the antisense primer was 5&#x2032;TCCCACCTTTGTTGGAAGTGAAAG3&#x2032;. The sense primer for SNP4 was 5&#x2032;CTGGTGAGTGTGACTATTGAAAGGG3&#x2032; and the antisense primer was 5&#x2032;TTAGTACCTGAAGACTGGAGAGTGAG3&#x2032;. Genotypes were determined automatically by the signal processing algorithms of Genotyping Console software 4.1 (Cleveland, OH, USA). To aid in the comparison of the results, each scoring method were saved in two separate output files.</p>
</sec>
<sec>
<title>Biochemical analysis</title>
<p>Serum concentrations of cholesterol and glucose were measuring using the standard methods employed by the Clinical Laboratory Department of the First Affiliated Hospital of Xinjiang Medical University.</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>All continuous variables were expressed as the mean &#x00B1; standard deviation. The Mann-Whitney U test was used to compare differences in continuous variables between RSM patients and controls. The Fisher&#x0027;s exact test was used to calculate differences in categorical variables. The Hardy-Weinberg equilibrium was analyzed using &#x03C7;<sup>2</sup> analysis. The Fisher&#x0027;s exact test was used to calculate differences in the distribution of genotypes and alleles between the RSM patients and controls. According to the genotype data resulting from the genetic variations, linkage disequilibrium analysis and haplotype-based case-control analysis was performed using the expectation maximization algorithm and SNPAlyze version 3.2 (Dynacom Co., Ltd., Yokohama, Japan). The four SNPs were used to perform pair-wise linkage disequilibrium analysis. D &#x003E;0.5 was used to assign SNP locations to one haplotype block. SNPs with r<sup>2</sup> &#x003C;0.5 were selected as tagged. A permutation test was used to calculate the frequency distribution of the haplotypes and P-values in the haplotype-based case-control analysis. The contribution of major risk factors was assessed using logistic regression analysis. P&#x003C;0.05 was considered to indicate a statistically significant difference. Statistical analyses were performed using SPSS software for Windows (version 12; SPSS Inc., Chicago, IL, USA).</p>
</sec>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>Clinical characteristics</title>
<p><xref rid="tI-etm-0-0-3796" ref-type="table">Table I</xref> presents the clinical characteristics of the study participants. In Uygur women, the age of menarche, systolic blood pressure, diastolic blood pressure and spontaneous miscarriages were significantly higher in RSM patients compared with the controls (P&#x003C;0.05). In Han women, systolic blood pressure, number of pregnancies, spontaneous miscarriages and the frequency of drinking were significantly higher in RSM patients compared with the controls (P&#x003C;0.05). There were no significant differences noted between RSM patients and the controls with regards to age, body mass index, pulse rate, serum cholesterol, serum glucose and the frequency of smoking in Uygur and Han women.</p>
</sec>
<sec>
<title>Distribution of genotypes</title>
<p><xref rid="tII-etm-0-0-3796" ref-type="table">Table II</xref> presents the distribution of the genotypes and alleles of the four SNPs. For each SNP, the genotype distributions in the controls were not significantly different from the Hardy-Weinberg equilibrium values (data not shown). In Uygur women, there were significant differences between the distributions of the rs1927914, rs1927911 and rs4986790 SNPs between the RSM patients and the controls (P=0.001, P&#x003C;0.001 and P=0.015, respectively). In Han women, there were significant differences between the distributions of the rs1927914 and rs1927911 SNPs between the RSM patients and the controls (P&#x003C;0.001 and P&#x003C;0.001, respectively).</p>
</sec>
<sec>
<title>Risk factors and SNPs</title>
<p>Parameters in <xref rid="tI-etm-0-0-3796" ref-type="table">Table I</xref> that exhibited significant differences between the RSM patients and the controls were used for the logistic regression analysis. In Uygur women, parameters used included SNPs (rs1927914, rs1927911 and rs4986790), the age of menarche, systolic blood pressure, diastolic blood pressure and spontaneous miscarriages. As shown in <xref rid="tIII-etm-0-0-3796" ref-type="table">Table III</xref>, results of the logistic regression analysis indicated that the distributions of rs1927914, rs1927911 and rs4986790 SNPs were significantly different in the RSM patients compared with the control individuals (P=0.012, P=0.024 and P=0.035, respectively). In addition, systolic blood pressure differed significantly between the RSM patients and the controls (P=0.011, P=0.021 and P=0.032, respectively) in Uygur women.</p>
<p>In Han women, parameters used included SNPs (rs1927914 and rs1927911), systolic blood pressure, number of pregnancies, spontaneous miscarriages and the frequency of drinking. As shown in <xref rid="tIV-etm-0-0-3796" ref-type="table">Table IV</xref>, results of the logistic regression analysis indicated that the distributions of rs1927914 and rs1927911 SNPs were significantly different in the RSM patients compared with the control individuals (P=0.021 and P=0.004, respectively) in Han women.</p>
</sec>
<sec>
<title>Haplotypes</title>
<p>Since most of the D-values of linkage disequilibrium for the human <italic>TLR4</italic> gene in the controls were &#x003E;0.5 (data not shown), this indicated that the four SNPs were located in one haplotype block. Since all of the r<sup>2</sup> values were &#x003C;0.5 (data not shown), this suggests that every SNP would be useful for the haplotype-based case-control study. Since rs4986791 (SNP4) has no allele distributions in RSM patients and the controls in this study, haplotypes were constructed using SNP1, SNP2 and SNP3. The distributions of the individual haplotypes for these combinations of the three SNPs were analyzed, and the results are presented in <xref rid="tV-etm-0-0-3796" ref-type="table">Table V</xref>. In Uygur women, significantly higher frequencies were noted for the A-G-G haplotype (SNP1-SNP2-SNP3; P=0.016) in RSM patients compared with the controls.</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>RSM is a reproductive problem, which affects 1&#x2013;3&#x0025; of couples trying to conceive (<xref rid="b12-etm-0-0-3796" ref-type="bibr">12</xref>). Epidemiological studies have suggested that RSM comprises a multifactorial condition enhanced by a variety of genetic and environmental factors (<xref rid="b13-etm-0-0-3796" ref-type="bibr">13</xref>). A number of studies have suggested that RSM is associated with genetic disorders that include skewed X chromosome inactivation (<xref rid="b14-etm-0-0-3796" ref-type="bibr">14</xref>), HLA-G (<xref rid="b15-etm-0-0-3796" ref-type="bibr">15</xref>), age-related aneuploidy (<xref rid="b16-etm-0-0-3796" ref-type="bibr">16</xref>), autoimmune disorders (<xref rid="b17-etm-0-0-3796" ref-type="bibr">17</xref>) and acquired or inherited thrombophilia (<xref rid="b18-etm-0-0-3796" ref-type="bibr">18</xref>). In addition, several studies have shown that nutritional and lifestyle factors, smoking, and diet (<xref rid="b19-etm-0-0-3796" ref-type="bibr">19</xref>,<xref rid="b20-etm-0-0-3796" ref-type="bibr">20</xref>) contribute to RSM pathogenesis. For instance, obesity has a greater incidence in RSM patients compared with controls (<xref rid="b21-etm-0-0-3796" ref-type="bibr">21</xref>). Furthermore, a woman&#x0027;s medical history (<xref rid="b3-etm-0-0-3796" ref-type="bibr">3</xref>) is important since the risk of RSM is increased by previous miscarriages (20&#x0025; after one miscarriage, 28&#x0025; after two miscarriages) and age (40&#x0025; risk for 40 year-old women, and 80&#x0025; for women 45 and older). Considering all these risk factors, the related data (including age, body mass index, number of pregnancies and number of spontaneous miscarriages) has been collected and presented in <xref rid="tI-etm-0-0-3796" ref-type="table">Table I</xref>. Then, the relationship between these risk factors and RSM is analyzed using logistic regression and presented in <xref rid="tIII-etm-0-0-3796" ref-type="table">Tables III</xref> and <xref rid="tIV-etm-0-0-3796" ref-type="table">IV</xref>.</p>
<p>TLR4 is present in numerous cell types and signals the innate immune response. TLR4 expression has been investigated in tumor cells or cell lines, including extranodal marginal zone B-cell lymphomas, gastric carcinoma, hepatocellular carcinoma cells, pituitary epithelial tumor cell lines, colon cancer cells and human prostate epithelial PC3 cells (<xref rid="b22-etm-0-0-3796" ref-type="bibr">22</xref>). The innate immune system is the first line of defense against microbial infection and TLR4 serves as the first point of defense in the innate immune system. TLR4 is one of the most extensively investigated TLRs and recognizes endotoxic lipopoly saccharide (LPS) in the outer membrane of Gram-negative bacteria with its co-receptor MD-2 (<xref rid="b23-etm-0-0-3796" ref-type="bibr">23</xref>). TLR4 is critical in the recognition of viruses and bacteria, serving as a key immune system effector. Excessive signaling in response to LPS frequently results in uncontrolled amplification of inflammatory responses, leading to fatal septic shock (<xref rid="b24-etm-0-0-3796" ref-type="bibr">24</xref>,<xref rid="b25-etm-0-0-3796" ref-type="bibr">25</xref>).</p>
<p>Dysregulation of TLR4 signalling owing to SNPs may alter the ligand binding and balance between pro- and anti-inflammatory cytokines, thereby modulating the risk of chronic inflammatory and immune disorders. Consequently, several studies have shown that common SNPs of a series of low penetrance alleles of TLR4, modified during the above mentioned processes, are likely to serve an important role in cancer susceptibility (<xref rid="b26-etm-0-0-3796" ref-type="bibr">26</xref>,<xref rid="b27-etm-0-0-3796" ref-type="bibr">27</xref>). Two SNPs of the human TLR4, A299G (ref SNP ID: rs4986790, SNP3) and T399I (ref SNP ID: rs4986791, SNP4), have been identified and suggested to be associated with LPS hyporesponsiveness (<xref rid="b28-etm-0-0-3796" ref-type="bibr">28</xref>,<xref rid="b29-etm-0-0-3796" ref-type="bibr">29</xref>). Furthermore, two non-synonymous polymorphisms of TLR4 (Asp299Gly and Thr399Ile) have been suggested to alter the function of the receptor (<xref rid="b30-etm-0-0-3796" ref-type="bibr">30</xref>,<xref rid="b31-etm-0-0-3796" ref-type="bibr">31</xref>) and have been related to the development of chronic inflammatory conditions (<xref rid="b32-etm-0-0-3796" ref-type="bibr">32</xref>). In addition, Hirschfeld <italic>et al</italic> (<xref rid="b33-etm-0-0-3796" ref-type="bibr">33</xref>) reported that there was no association between fetal TLR4 polymorphisms, Asp299Gly and Thr399Ile, known to blunt LPS responsiveness, and the risk of idiopathic, chromosomally normal miscarriage. However, how the SNPs affect the function of TLR4 remains largely unknown.</p>
<p>The aim of the present study was to assess the association between the human <italic>TLR4</italic> gene and RSM in Uygur and Han women in Xinjiang by using a haplotype-based case-control study. The results of the genotype distributions and logistic regression analysis indicated that rs1927914, rs1927911 and rs4986790 are most likely associated with RSM in Uygur women, while rs1927914 and rs1927911 are most likely associated with RSM in Han women. Additionally, logistic regression analysis indicated that systolic blood pressure is one of the risk factors for RSM patients, which is consistent with results of a previous study (<xref rid="b34-etm-0-0-3796" ref-type="bibr">34</xref>).</p>
<p>It has been demonstrated that haplotypes can provide valuable information that can be used for predicting the severity and prognosis of certain genetic disorders (<xref rid="b35-etm-0-0-3796" ref-type="bibr">35</xref>). With the dramatic increase in the number of available SNP markers, haplotyping based on genotype data has become an important component of genetic studies in general and has shown that these types of studies have a number of advantages over analyses that are just based on individual SNPs (<xref rid="b36-etm-0-0-3796" ref-type="bibr">36</xref>). In the present study, haplotypes for the human <italic>TLR4</italic> gene were successfully established that were created from the combinations of the three SNPs. In the present haplotype analysis, there was a significantly higher frequency of the A-G-G haplotype (SNP1-SNP2-SNP3) in RSM patients compared with the controls in Uygur women. Therefore, it can be suggested that the result indicates that the A-G-G haplotype (SNP1-SNP2-SNP3) is the susceptibility haplotype for RSM in Uygur women, and it can be proposed that the A-G-G haplotype (SNP1-SNP2-SNP3) should be regarded as the genetic marker for RSM in Uygur women in Xinjiang. In addition, for SNP3, the G allele is the risk allele while the A allele is the safe allele for RSM in Uygur women.</p>
<p>To date, to the best of our knowledge, there have been no previous studies that have reported data on the association between TLR4 and RSM in Uygur women. Therefore, the current results provide novel data on the possibility that the <italic>TLR4</italic> gene is most likely associated with RSM, and rs4986790 may be the nationality-specific genetic marker for RSM for Uygur women.</p>
<p>In conclusion, the present study examined the association between the human <italic>TLR4</italic> gene and RSM. The present results indicate that rs1927914, rs1927911, rs4986790 and the A-G-G haplotype of the human <italic>TLR4</italic> gene may be genetic markers for RSM in Uygur women in Xinjiang. In addition, the results suggest that rs1927914 and rs1927911 of the human <italic>TLR4</italic> gene are most likely associated with RSM in Han women. Further studies are required to elucidate the functional association of TLR4 with RSM progression.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="b1-etm-0-0-3796"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rai</surname><given-names>R</given-names></name><name><surname>Regan</surname><given-names>L</given-names></name></person-group><article-title>Recurrent miscarriage</article-title><source>Lancet</source><volume>368</volume><fpage>601</fpage><lpage>611</lpage><year>2006</year><pub-id pub-id-type="doi">10.1016/S0140-6736(06)69204-0</pub-id><pub-id pub-id-type="pmid">16905025</pub-id></element-citation></ref>
<ref id="b2-etm-0-0-3796"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cramer</surname><given-names>DW</given-names></name><name><surname>Wise</surname><given-names>LA</given-names></name></person-group><article-title>The epidemiology of recurrent pregnancy loss</article-title><source>Semin Reprod Med</source><volume>18</volume><fpage>331</fpage><lpage>339</lpage><year>2000</year><pub-id pub-id-type="doi">10.1055/s-2000-13722</pub-id><pub-id pub-id-type="pmid">11355791</pub-id></element-citation></ref>
<ref id="b3-etm-0-0-3796"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ford</surname><given-names>HB</given-names></name><name><surname>Schust</surname><given-names>DJ</given-names></name></person-group><article-title>Recurrent pregnancy loss: Etiology, diagnosis, and therapy</article-title><source>Rev Obstet Gynecol</source><volume>2</volume><fpage>76</fpage><lpage>83</lpage><year>2009</year><pub-id pub-id-type="pmid">19609401</pub-id></element-citation></ref>
<ref id="b4-etm-0-0-3796"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akira</surname><given-names>S</given-names></name><name><surname>Takeda</surname><given-names>K</given-names></name></person-group><article-title>Functions of toll-like receptors: Lessons from KO mice</article-title><source>C R Biol</source><volume>327</volume><fpage>581</fpage><lpage>589</lpage><year>2004</year><pub-id pub-id-type="doi">10.1016/j.crvi.2004.04.002</pub-id><pub-id pub-id-type="pmid">15330257</pub-id></element-citation></ref>
<ref id="b5-etm-0-0-3796"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawai</surname><given-names>T</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name></person-group><article-title>The role of pattern-recognition receptors in innate immunity: Update on Toll-like receptors</article-title><source>Nat Immunol</source><volume>11</volume><fpage>373</fpage><lpage>384</lpage><year>2010</year><pub-id pub-id-type="doi">10.1038/ni.1863</pub-id><pub-id pub-id-type="pmid">20404851</pub-id></element-citation></ref>
<ref id="b6-etm-0-0-3796"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshak-Rothstein</surname><given-names>A</given-names></name></person-group><article-title>Toll-like receptors in systemic autoimmune disease</article-title><source>Nat Rev Immunol</source><volume>6</volume><fpage>823</fpage><lpage>835</lpage><year>2006</year><pub-id pub-id-type="doi">10.1038/nri1957</pub-id><pub-id pub-id-type="pmid">17063184</pub-id></element-citation></ref>
<ref id="b7-etm-0-0-3796"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schroder</surname><given-names>NW</given-names></name><name><surname>Schumann</surname><given-names>RR</given-names></name></person-group><article-title>Single nucleotide polymorphisms of toll-like receptors and susceptibility to infectious disease</article-title><source>Lancet Infect Dis</source><volume>5</volume><fpage>156</fpage><lpage>164</lpage><year>2005</year><pub-id pub-id-type="doi">10.1016/S1473-3099(05)01308-3</pub-id><pub-id pub-id-type="pmid">15766650</pub-id></element-citation></ref>
<ref id="b8-etm-0-0-3796"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horie</surname><given-names>Y</given-names></name><name><surname>Meguro</surname><given-names>A</given-names></name><name><surname>Ota</surname><given-names>M</given-names></name><name><surname>Kitaichi</surname><given-names>N</given-names></name><name><surname>Katsuyama</surname><given-names>Y</given-names></name><name><surname>Takemoto</surname><given-names>Y</given-names></name><name><surname>Namba</surname><given-names>K</given-names></name><name><surname>Yoshida</surname><given-names>K</given-names></name><name><surname>Song</surname><given-names>YW</given-names></name><name><surname>Park</surname><given-names>KS</given-names></name><etal/></person-group><article-title>Association of TLR4 polymorphisms with Behcet&#x0027;s disease in a Korean population</article-title><source>Rheumatology (Oxford)</source><volume>48</volume><fpage>638</fpage><lpage>642</lpage><year>2009</year><pub-id pub-id-type="doi">10.1093/rheumatology/kep077</pub-id><pub-id pub-id-type="pmid">19395541</pub-id></element-citation></ref>
<ref id="b9-etm-0-0-3796"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pabst</surname><given-names>S</given-names></name><name><surname>Baumgarten</surname><given-names>G</given-names></name><name><surname>Stremmel</surname><given-names>A</given-names></name><name><surname>Lennarz</surname><given-names>M</given-names></name><name><surname>Kn&#x00FC;fermann</surname><given-names>P</given-names></name><name><surname>Gillissen</surname><given-names>A</given-names></name><name><surname>Vetter</surname><given-names>H</given-names></name><name><surname>Groh&#x00E9;</surname><given-names>C</given-names></name></person-group><article-title>Toll-like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis</article-title><source>Clin Exp Immunol</source><volume>143</volume><fpage>420</fpage><lpage>426</lpage><year>2006</year><pub-id pub-id-type="doi">10.1111/j.1365-2249.2006.03008.x</pub-id><pub-id pub-id-type="pmid">16487240</pub-id></element-citation></ref>
<ref id="b10-etm-0-0-3796"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frantz</surname><given-names>S</given-names></name><name><surname>Ertl</surname><given-names>G</given-names></name><name><surname>Bauersachs</surname><given-names>J</given-names></name></person-group><article-title>Mechanisms of disease: Toll-like receptors in cardiovascular disease</article-title><source>Nat Clin Pract Cardiovasc Med</source><volume>4</volume><fpage>444</fpage><lpage>454</lpage><year>2007</year><pub-id pub-id-type="doi">10.1038/ncpcardio0938</pub-id><pub-id pub-id-type="pmid">17653117</pub-id></element-citation></ref>
<ref id="b11-etm-0-0-3796"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varshney</surname><given-names>RK</given-names></name><name><surname>Kudapa</surname><given-names>H</given-names></name><name><surname>Roorkiwal</surname><given-names>M</given-names></name><name><surname>Thudi</surname><given-names>M</given-names></name><name><surname>Pandey</surname><given-names>MK</given-names></name><name><surname>Saxena</surname><given-names>RK</given-names></name><name><surname>Chamarthi</surname><given-names>SK</given-names></name><name><surname>Mohan</surname><given-names>SM</given-names></name><name><surname>Mallikarjuna</surname><given-names>N</given-names></name><name><surname>Upadhyaya</surname><given-names>H</given-names></name><etal/></person-group><article-title>Advances in genetics and molecular breeding of three legume crops of semi-arid tropics using next-generation sequencing and high-throughput genotyping technologies</article-title><source>J Biosci</source><volume>37</volume><fpage>811</fpage><lpage>820</lpage><year>2012</year><pub-id pub-id-type="doi">10.1007/s12038-012-9228-0</pub-id><pub-id pub-id-type="pmid">23107917</pub-id></element-citation></ref>
<ref id="b12-etm-0-0-3796"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sierra</surname><given-names>S</given-names></name><name><surname>Stephenson</surname><given-names>M</given-names></name></person-group><article-title>Genetics of recurrent pregnancy loss</article-title><source>Semin Reprod Med</source><volume>24</volume><fpage>17</fpage><lpage>24</lpage><year>2006</year><pub-id pub-id-type="doi">10.1055/s-2006-931797</pub-id><pub-id pub-id-type="pmid">16418974</pub-id></element-citation></ref>
<ref id="b13-etm-0-0-3796"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cramer</surname><given-names>DW</given-names></name><name><surname>Wise</surname><given-names>LA</given-names></name></person-group><article-title>The epidemiology of recurrent pregnancy loss</article-title><source>Semin Reprod Med</source><volume>18</volume><fpage>331</fpage><lpage>339</lpage><year>2000</year><pub-id pub-id-type="doi">10.1055/s-2000-13722</pub-id><pub-id pub-id-type="pmid">11355791</pub-id></element-citation></ref>
<ref id="b14-etm-0-0-3796"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuo</surname><given-names>PL</given-names></name><name><surname>Huang</surname><given-names>SC</given-names></name><name><surname>Chang</surname><given-names>LW</given-names></name><name><surname>Lin</surname><given-names>CH</given-names></name><name><surname>Tsai</surname><given-names>WH</given-names></name><name><surname>Teng</surname><given-names>YN</given-names></name></person-group><article-title>Association of extremely skewed X-chromosome inactivation with Taiwanese women presenting with recurrent pregnancy loss</article-title><source>J Formos Med Assoc</source><volume>107</volume><fpage>340</fpage><lpage>343</lpage><year>2008</year><pub-id pub-id-type="doi">10.1016/S0929-6646(08)60096-0</pub-id><pub-id pub-id-type="pmid">18445549</pub-id></element-citation></ref>
<ref id="b15-etm-0-0-3796"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeiffer</surname><given-names>KA</given-names></name><name><surname>Fimmers</surname><given-names>R</given-names></name><name><surname>Engels</surname><given-names>G</given-names></name><name><surname>van der Ven</surname><given-names>H</given-names></name><name><surname>van der Ven</surname><given-names>K</given-names></name></person-group><article-title>The HLA-G genotype is potentially associated with idiopathic recurrent spontaneous abortion</article-title><source>Mol Hum Reprod</source><volume>7</volume><fpage>373</fpage><lpage>378</lpage><year>2001</year><pub-id pub-id-type="doi">10.1093/molehr/7.4.373</pub-id><pub-id pub-id-type="pmid">11279300</pub-id></element-citation></ref>
<ref id="b16-etm-0-0-3796"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hodes-Wertz</surname><given-names>B</given-names></name><name><surname>Grifo</surname><given-names>J</given-names></name><name><surname>Ghadir</surname><given-names>S</given-names></name><name><surname>Kaplan</surname><given-names>B</given-names></name><name><surname>Laskin</surname><given-names>CA</given-names></name><name><surname>Glassner</surname><given-names>M</given-names></name><name><surname>Munn&#x00E9;</surname><given-names>S</given-names></name></person-group><article-title>Idiopathic recurrent miscarriage is caused mostly by aneuploid embryos</article-title><source>Fertil Steril</source><volume>98</volume><fpage>675</fpage><lpage>680</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.fertnstert.2012.05.025</pub-id><pub-id pub-id-type="pmid">22683012</pub-id></element-citation></ref>
<ref id="b17-etm-0-0-3796"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finan</surname><given-names>RR</given-names></name><name><surname>Al-Irhayim</surname><given-names>Z</given-names></name><name><surname>Mustafa</surname><given-names>FE</given-names></name><name><surname>Al-Zaman</surname><given-names>I</given-names></name><name><surname>Mohammed</surname><given-names>FA</given-names></name><name><surname>Al-Khateeb</surname><given-names>GM</given-names></name><name><surname>Madan</surname><given-names>S</given-names></name><name><surname>Issa</surname><given-names>AA</given-names></name><name><surname>Almawi</surname><given-names>WY</given-names></name></person-group><article-title>Tumor necrosis factor-alpha polymorphisms in women with idiopathic recurrent miscarriage</article-title><source>J Reprod Immunol</source><volume>84</volume><fpage>186</fpage><lpage>192</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.jri.2009.12.005</pub-id><pub-id pub-id-type="pmid">20106534</pub-id></element-citation></ref>
<ref id="b18-etm-0-0-3796"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paidas</surname><given-names>MJ</given-names></name><name><surname>Ku</surname><given-names>DH</given-names></name><name><surname>Langhoff-Roos</surname><given-names>J</given-names></name><name><surname>Arkel</surname><given-names>YS</given-names></name></person-group><article-title>Inherited thrombophilias and adverse pregnancy outcome: Screening and management</article-title><source>Semin Perinatol</source><volume>29</volume><fpage>150</fpage><lpage>163</lpage><year>2005</year><pub-id pub-id-type="doi">10.1053/j.semperi.2005.05.008</pub-id><pub-id pub-id-type="pmid">16114578</pub-id></element-citation></ref>
<ref id="b19-etm-0-0-3796"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metwally</surname><given-names>M</given-names></name><name><surname>Saravelos</surname><given-names>SH</given-names></name><name><surname>Ledger</surname><given-names>WL</given-names></name><name><surname>Li</surname><given-names>TC</given-names></name></person-group><article-title>Body mass index and risk of miscarriage in women with recurrent miscarriage</article-title><source>Fertil Steril</source><volume>94</volume><fpage>290</fpage><lpage>295</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.fertnstert.2009.03.021</pub-id><pub-id pub-id-type="pmid">19439294</pub-id></element-citation></ref>
<ref id="b20-etm-0-0-3796"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dasarathy</surname><given-names>J</given-names></name><name><surname>Gruca</surname><given-names>LL</given-names></name><name><surname>Bennett</surname><given-names>C</given-names></name><name><surname>Parimi</surname><given-names>PS</given-names></name><name><surname>Duenas</surname><given-names>C</given-names></name><name><surname>Marczewski</surname><given-names>S</given-names></name><name><surname>Fierro</surname><given-names>JL</given-names></name><name><surname>Kalhan</surname><given-names>SC</given-names></name></person-group><article-title>Methionine metabolism in human pregnancy</article-title><source>Am J Clin Nutr</source><volume>91</volume><fpage>357</fpage><lpage>365</lpage><year>2010</year><pub-id pub-id-type="doi">10.3945/ajcn.2009.28457</pub-id><pub-id pub-id-type="pmid">19939983</pub-id></element-citation></ref>
<ref id="b21-etm-0-0-3796"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x0027;Dwyer</surname><given-names>V</given-names></name><name><surname>Monaghan</surname><given-names>B</given-names></name><name><surname>Fattah</surname><given-names>C</given-names></name><name><surname>Farah</surname><given-names>N</given-names></name><name><surname>Kennelly</surname><given-names>MM</given-names></name><name><surname>Turner</surname><given-names>MJ</given-names></name></person-group><article-title>Miscarriage after sonographic confirmation of an ongoing pregnancy in women with moderate and severe obesity</article-title><source>Obes Facts</source><volume>5</volume><fpage>393</fpage><lpage>398</lpage><year>2012</year><pub-id pub-id-type="doi">10.1159/000336253</pub-id><pub-id pub-id-type="pmid">22797366</pub-id></element-citation></ref>
<ref id="b22-etm-0-0-3796"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bulut</surname><given-names>Y</given-names></name><name><surname>Faure</surname><given-names>E</given-names></name><name><surname>Thomas</surname><given-names>L</given-names></name><name><surname>Karahashi</surname><given-names>H</given-names></name><name><surname>Michelsen</surname><given-names>KS</given-names></name><name><surname>Equils</surname><given-names>O</given-names></name><name><surname>Morrison</surname><given-names>SG</given-names></name><name><surname>Morrison</surname><given-names>RP</given-names></name><name><surname>Arditi</surname><given-names>M</given-names></name></person-group><article-title>Chlamydial heat shock protein 60 activates macrophages and endothelial cells through toll-like receptor 4 and MD2 in a MyD88-dependent pathway</article-title><source>J Immunol</source><volume>168</volume><fpage>1435</fpage><lpage>1440</lpage><year>2002</year><pub-id pub-id-type="doi">10.4049/jimmunol.168.3.1435</pub-id><pub-id pub-id-type="pmid">11801686</pub-id></element-citation></ref>
<ref id="b23-etm-0-0-3796"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poltorak</surname><given-names>A</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Smirnova</surname><given-names>I</given-names></name><name><surname>Liu</surname><given-names>MY</given-names></name><name><surname>Van Huffel</surname><given-names>C</given-names></name><name><surname>Du</surname><given-names>X</given-names></name><name><surname>Birdwell</surname><given-names>D</given-names></name><name><surname>Alejos</surname><given-names>E</given-names></name><name><surname>Silva</surname><given-names>M</given-names></name><name><surname>Galanos</surname><given-names>C</given-names></name><etal/></person-group><article-title>Defective LPS signalingin C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene</article-title><source>Science</source><volume>282</volume><fpage>2085</fpage><lpage>2088</lpage><year>1998</year><pub-id pub-id-type="doi">10.1126/science.282.5396.2085</pub-id><pub-id pub-id-type="pmid">9851930</pub-id></element-citation></ref>
<ref id="b24-etm-0-0-3796"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angus</surname><given-names>DC</given-names></name><name><surname>Linde-Zwirble</surname><given-names>WT</given-names></name><name><surname>Lidicker</surname><given-names>J</given-names></name><name><surname>Clermont</surname><given-names>G</given-names></name><name><surname>Carcillo</surname><given-names>J</given-names></name><name><surname>Pinsky</surname><given-names>MR</given-names></name></person-group><article-title>Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care</article-title><source>Crit Care Med</source><volume>29</volume><fpage>1303</fpage><lpage>1310</lpage><year>2001</year><pub-id pub-id-type="doi">10.1097/00003246-200107000-00002</pub-id><pub-id pub-id-type="pmid">11445675</pub-id></element-citation></ref>
<ref id="b25-etm-0-0-3796"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rangel-Frausto</surname><given-names>MS</given-names></name></person-group><article-title>Sepsis: Still going strong</article-title><source>Arch Med Res</source><volume>36</volume><fpage>672</fpage><lpage>681</lpage><year>2005</year><pub-id pub-id-type="doi">10.1016/j.arcmed.2005.06.006</pub-id><pub-id pub-id-type="pmid">16216648</pub-id></element-citation></ref>
<ref id="b26-etm-0-0-3796"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zidi</surname><given-names>S</given-names></name><name><surname>Verdi</surname><given-names>H</given-names></name><name><surname>Yilmaz-Yalcin</surname><given-names>Y</given-names></name><name><surname>Yazici</surname><given-names>AC</given-names></name><name><surname>Gazouani</surname><given-names>E</given-names></name><name><surname>Mezlini</surname><given-names>A</given-names></name><name><surname>Atac</surname><given-names>FB</given-names></name><name><surname>Yacoubi-Loueslati</surname><given-names>B</given-names></name></person-group><article-title>Involvement of Toll-like receptors in cervical cancer susceptibility among Tunisian women</article-title><source>Bull Cancer</source><volume>101</volume><fpage>E31</fpage><lpage>E35</lpage><year>2014</year><pub-id pub-id-type="pmid">25373689</pub-id></element-citation></ref>
<ref id="b27-etm-0-0-3796"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>C</given-names></name><name><surname>Tu</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>Q</given-names></name><name><surname>Gong</surname><given-names>Y</given-names></name><name><surname>Jing</surname><given-names>J</given-names></name><name><surname>Dong</surname><given-names>N</given-names></name><name><surname>Yuan</surname><given-names>Y</given-names></name></person-group><article-title>SNP interactions of Helicobacter pylori-related host genes PGC, PTPN11, IL1B, and TLR4 in susceptibility to gastric carcinogenesis</article-title><source>Oncotarget</source><volume>6</volume><fpage>19017</fpage><lpage>19026</lpage><year>2015</year><pub-id pub-id-type="doi">10.18632/oncotarget.4231</pub-id><pub-id pub-id-type="pmid">26158864</pub-id></element-citation></ref>
<ref id="b28-etm-0-0-3796"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rallabhandi</surname><given-names>P</given-names></name><name><surname>Bell</surname><given-names>J</given-names></name><name><surname>Boukhvalova</surname><given-names>MS</given-names></name><name><surname>Medvedev</surname><given-names>A</given-names></name><name><surname>Lorenz</surname><given-names>E</given-names></name><name><surname>Arditi</surname><given-names>M</given-names></name><name><surname>Hemming</surname><given-names>VG</given-names></name><name><surname>Blanco</surname><given-names>JC</given-names></name><name><surname>Segal</surname><given-names>DM</given-names></name><name><surname>Vogel</surname><given-names>SN</given-names></name></person-group><article-title>Analysis of TLR4 polymorphic variants: New insights into TLR4/ MD-2/CD14 stoichiometry, structure, and signaling</article-title><source>J Immunol</source><volume>177</volume><fpage>322</fpage><lpage>332</lpage><year>2006</year><pub-id pub-id-type="doi">10.4049/jimmunol.177.1.322</pub-id><pub-id pub-id-type="pmid">16785528</pub-id></element-citation></ref>
<ref id="b29-etm-0-0-3796"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Figueroa</surname><given-names>L</given-names></name><name><surname>Xiong</surname><given-names>Y</given-names></name><name><surname>Song</surname><given-names>C</given-names></name><name><surname>Piao</surname><given-names>W</given-names></name><name><surname>Vogel</surname><given-names>SN</given-names></name><name><surname>Medvedev</surname><given-names>AE</given-names></name></person-group><article-title>The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF</article-title><source>J Immunol</source><volume>188</volume><fpage>4506</fpage><lpage>4515</lpage><year>2012</year><pub-id pub-id-type="doi">10.4049/jimmunol.1200202</pub-id><pub-id pub-id-type="pmid">22474023</pub-id></element-citation></ref>
<ref id="b30-etm-0-0-3796"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arbour</surname><given-names>NC</given-names></name><name><surname>Lorenz</surname><given-names>E</given-names></name><name><surname>Schutte</surname><given-names>BC</given-names></name><name><surname>Zabner</surname><given-names>J</given-names></name><name><surname>Kline</surname><given-names>JN</given-names></name><name><surname>Jones</surname><given-names>M</given-names></name><name><surname>Frees</surname><given-names>K</given-names></name><name><surname>Watt</surname><given-names>JL</given-names></name><name><surname>Schwartz</surname><given-names>DA</given-names></name></person-group><article-title>TLR4 mutations are associated with endotoxin hyporesponsiveness in humans</article-title><source>Nat Genet</source><volume>25</volume><fpage>187</fpage><lpage>191</lpage><year>2000</year><pub-id pub-id-type="doi">10.1038/76048</pub-id><pub-id pub-id-type="pmid">10835634</pub-id></element-citation></ref>
<ref id="b31-etm-0-0-3796"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferwerda</surname><given-names>B</given-names></name><name><surname>McCall</surname><given-names>MB</given-names></name><name><surname>Verheijen</surname><given-names>K</given-names></name><name><surname>Kullberg</surname><given-names>BJ</given-names></name><name><surname>van der Ven</surname><given-names>AJ</given-names></name><name><surname>Van der Meer</surname><given-names>JW</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name></person-group><article-title>Functional consequences of Toll-like receptor 4 polymorphisms</article-title><source>Mol Med</source><volume>14</volume><fpage>346</fpage><lpage>352</lpage><year>2008</year><pub-id pub-id-type="doi">10.2119/2007-00135.Ferwerda</pub-id><pub-id pub-id-type="pmid">18231573</pub-id></element-citation></ref>
<ref id="b32-etm-0-0-3796"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radstake</surname><given-names>TR</given-names></name><name><surname>Franke</surname><given-names>B</given-names></name><name><surname>Hanssen</surname><given-names>S</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Welsing</surname><given-names>P</given-names></name><name><surname>Barrera</surname><given-names>P</given-names></name><name><surname>Joosten</surname><given-names>LA</given-names></name><name><surname>van Riel</surname><given-names>PL</given-names></name><name><surname>van den Berg</surname><given-names>WB</given-names></name></person-group><article-title>The toll-like receptor 4 Asp299Gly functional variant is associated with decreased rheumatoid arthritis disease susceptibility but does not influence disease severity and/or outcome</article-title><source>Arthritis Rheum</source><volume>50</volume><fpage>999</fpage><lpage>1001</lpage><year>2004</year><pub-id pub-id-type="doi">10.1002/art.20114</pub-id><pub-id pub-id-type="pmid">15022344</pub-id></element-citation></ref>
<ref id="b33-etm-0-0-3796"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirschfeld</surname><given-names>AF</given-names></name><name><surname>Jiang</surname><given-names>R</given-names></name><name><surname>Robinson</surname><given-names>WP</given-names></name><name><surname>McFadden</surname><given-names>DE</given-names></name><name><surname>Turvey</surname><given-names>SE</given-names></name></person-group><article-title>Toll-like receptor 4 polymorphisms and idiopathic chromosomally normal miscarriage</article-title><source>Hum Reprod</source><volume>22</volume><fpage>440</fpage><lpage>443</lpage><year>2007</year><pub-id pub-id-type="doi">10.1093/humrep/del377</pub-id><pub-id pub-id-type="pmid">16982657</pub-id></element-citation></ref>
<ref id="b34-etm-0-0-3796"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almawi</surname><given-names>WY</given-names></name><name><surname>Saldanha</surname><given-names>FL</given-names></name><name><surname>Mahmood</surname><given-names>NA</given-names></name><name><surname>Al-Zaman</surname><given-names>I</given-names></name><name><surname>Sater</surname><given-names>MS</given-names></name><name><surname>Mustafa</surname><given-names>FE</given-names></name></person-group><article-title>Relationship between VEGFA polymorphisms and serum VEGF protein levels and recurrent spontaneous miscarriage</article-title><source>Hum Reprod</source><volume>28</volume><fpage>2628</fpage><lpage>2635</lpage><year>2013</year><pub-id pub-id-type="doi">10.1093/humrep/det308</pub-id><pub-id pub-id-type="pmid">23900206</pub-id></element-citation></ref>
<ref id="b35-etm-0-0-3796"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>CK</given-names></name><name><surname>Yu</surname><given-names>HT</given-names></name><name><surname>Soong</surname><given-names>YK</given-names></name><name><surname>Lee</surname><given-names>CL</given-names></name></person-group><article-title>New perspectives on preimplantation genetic diagnosis and preimplantation genetic screening</article-title><source>Taiwan J Obstet Gynecol</source><volume>53</volume><fpage>146</fpage><lpage>150</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/j.tjog.2014.04.004</pub-id><pub-id pub-id-type="pmid">25017257</pub-id></element-citation></ref>
<ref id="b36-etm-0-0-3796"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname><given-names>CM</given-names></name><name><surname>Elston</surname><given-names>RC</given-names></name></person-group><article-title>Finding genes underlying human disease</article-title><source>Clin Genet</source><volume>75</volume><fpage>101</fpage><lpage>106</lpage><year>2009</year><pub-id pub-id-type="doi">10.1111/j.1399-0004.2008.01083.x</pub-id><pub-id pub-id-type="pmid">18783406</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-etm-0-0-3796" position="float">
<label>Figure 1.</label>
<caption><p>Structure of the human <italic>TLR4</italic> gene. The gene consists of four exons (boxes) separated by three introns. Lines connecting the boxes indicate introns and intergenic regions. The filled boxes show the coding region. Arrows indicate the locations of single-nucleotide polymorphisms. Kbp, kilobase pairs.</p></caption>
<graphic xlink:href="etm-12-05-3268-g00.tif"/>
</fig>
<table-wrap id="tI-etm-0-0-3796" position="float">
<label>Table I.</label>
<caption><p>Characteristics of study participants.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th align="center" valign="bottom" colspan="3">Uygur</th>
<th align="center" valign="bottom" colspan="3">Han</th>
</tr>
<tr>
<th/>
<th align="center" valign="bottom" colspan="3"><hr/></th>
<th align="center" valign="bottom" colspan="3"><hr/></th>
</tr>
<tr>
<th align="left" valign="bottom">Characteristic</th>
<th align="center" valign="bottom">RSM patients</th>
<th align="center" valign="bottom">Controls</th>
<th align="center" valign="bottom">P-value</th>
<th align="center" valign="bottom">RSM patients</th>
<th align="center" valign="bottom">Controls</th>
<th align="center" valign="bottom">P-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Number of subjects</td>
<td align="center" valign="top">154</td>
<td align="center" valign="top">155</td>
<td align="center" valign="top">&#x2013;</td>
<td align="center" valign="top">152</td>
<td align="center" valign="top">151</td>
<td align="center" valign="top">&#x2013;</td>
</tr>
<tr>
<td align="left" valign="top">Age (years)</td>
<td align="center" valign="top">35.2&#x00B1;3.7</td>
<td align="center" valign="top">35.1&#x00B1;4.5</td>
<td align="center" valign="top">0.859</td>
<td align="center" valign="top">35.6&#x00B1;4.1</td>
<td align="center" valign="top">35.7&#x00B1;3.8</td>
<td align="center" valign="top">0.643</td>
</tr>
<tr>
<td align="left" valign="top">Body mass index (kg/m<sup>2</sup>)</td>
<td align="center" valign="top">23.2&#x00B1;2.9</td>
<td align="center" valign="top">22.8&#x00B1;2.7</td>
<td align="center" valign="top">0.261</td>
<td align="center" valign="top">22.5&#x00B1;4.4</td>
<td align="center" valign="top">21.6&#x00B1;3.0</td>
<td align="center" valign="top">0.066</td>
</tr>
<tr>
<td align="left" valign="top">Menarche (years)</td>
<td align="center" valign="top">11.8&#x00B1;2.6</td>
<td align="center" valign="top">12.4&#x00B1;3.9</td>
<td align="center" valign="top">0.002<sup><xref rid="tfn1-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">12.3&#x00B1;3.9</td>
<td align="center" valign="top">12.5&#x00B1;4.2</td>
<td align="center" valign="top">0.127</td>
</tr>
<tr>
<td align="left" valign="top">Systolic blood pressure (mmHg)</td>
<td align="center" valign="top">110.8&#x00B1;15.2</td>
<td align="center" valign="top">119.3&#x00B1;14.3</td>
<td align="center" valign="top">&#x003C;0.001<sup><xref rid="tfn1-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">113.1&#x00B1;14.7</td>
<td align="center" valign="top">120.8&#x00B1;13.6</td>
<td align="center" valign="top">&#x003C;0.001<sup><xref rid="tfn1-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">Diastolic blood pressure (mmHg)</td>
<td align="center" valign="top">71.8&#x00B1;12.5</td>
<td align="center" valign="top">75.2&#x00B1;13.9</td>
<td align="center" valign="top">&#x003C;0.001<sup><xref rid="tfn1-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">75.5&#x00B1;9.7</td>
<td align="center" valign="top">76.6&#x00B1;11.4</td>
<td align="center" valign="top">0.232</td>
</tr>
<tr>
<td align="left" valign="top">Pulse rate (beats/min)</td>
<td align="center" valign="top">75.8&#x00B1;8.1</td>
<td align="center" valign="top">75.1&#x00B1;7.2</td>
<td align="center" valign="top">0.356</td>
<td align="center" valign="top">75.1&#x00B1;6.3</td>
<td align="center" valign="top">74.6&#x00B1;5.8</td>
<td align="center" valign="top">0.438</td>
</tr>
<tr>
<td align="left" valign="top">Cholesterol (mmol/l)</td>
<td align="center" valign="top">5.3&#x00B1;1.1</td>
<td align="center" valign="top">4.7&#x00B1;0.9</td>
<td align="center" valign="top">0.061</td>
<td align="center" valign="top">5.2&#x00B1;1.0</td>
<td align="center" valign="top">4.8&#x00B1;1.1</td>
<td align="center" valign="top">0.132</td>
</tr>
<tr>
<td align="left" valign="top">Glucose (mmol/l)</td>
<td align="center" valign="top">5.2&#x00B1;0.6</td>
<td align="center" valign="top">5.1&#x00B1;0.7</td>
<td align="center" valign="top">0.677</td>
<td align="center" valign="top">5.4&#x00B1;0.3</td>
<td align="center" valign="top">5.3&#x00B1;0.8</td>
<td align="center" valign="top">0.547</td>
</tr>
<tr>
<td align="left" valign="top">Number of pregnancies</td>
<td align="center" valign="top">4.5&#x00B1;0.7</td>
<td align="center" valign="top">4.1&#x00B1;0.5</td>
<td align="center" valign="top">0.125</td>
<td align="center" valign="top">4.2&#x00B1;0.8</td>
<td align="center" valign="top">1.8&#x00B1;0.9</td>
<td align="center" valign="top">&#x003C;0.001<sup><xref rid="tfn1-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">Spontaneous miscarriages</td>
<td align="center" valign="top">4.1&#x00B1;0.9</td>
<td align="center" valign="top">0&#x00B1;0.0</td>
<td align="center" valign="top">&#x003C;0.001<sup><xref rid="tfn1-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">3.8&#x00B1;0.7</td>
<td align="center" valign="top">0&#x00B1;0.0</td>
<td align="center" valign="top">&#x003C;0.001<sup><xref rid="tfn1-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">Smoking (&#x0025;)</td>
<td align="center" valign="top">1.9</td>
<td align="center" valign="top">2.6</td>
<td align="center" valign="top">0.500</td>
<td align="center" valign="top">3.3</td>
<td align="center" valign="top">3.3</td>
<td align="center" valign="top">0.621</td>
</tr>
<tr>
<td align="left" valign="top">Drinking (&#x0025;)</td>
<td align="center" valign="top">12.3</td>
<td align="center" valign="top">13.5</td>
<td align="center" valign="top">0.321</td>
<td align="center" valign="top">21.1</td>
<td align="center" valign="top">14.6</td>
<td align="center" valign="top">0.046<sup><xref rid="tfn1-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn1-etm-0-0-3796"><label>a</label><p>P&#x003C;0.05. Continuous variables are expressed as the mean &#x00B1; standard deviation. P-values of continuous variables were calculated by Mann-Whitney U test. P-values of categorical variables were calculated by Fisher&#x0027;s exact test. RSM, recurrent spontaneous miscarriage.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tII-etm-0-0-3796" position="float">
<label>Table II.</label>
<caption><p>Genotype and allele distributions in RSM patients and controls.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th align="center" valign="bottom" colspan="3">Uygur</th>
<th align="center" valign="bottom" colspan="3">Han</th>
</tr>
<tr>
<th/>
<th align="center" valign="bottom" colspan="3"><hr/></th>
<th align="center" valign="bottom" colspan="3"><hr/></th>
</tr>
<tr>
<th/>
<th align="center" valign="bottom">RSM patients</th>
<th align="center" valign="bottom">Controls</th>
<th align="center" valign="bottom">P-value</th>
<th align="center" valign="bottom">RSM patients</th>
<th align="center" valign="bottom">Controls</th>
<th align="center" valign="bottom">P-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">rs1927914 (SNP1)</td>
<td colspan="6"/>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Genotype</td>
<td colspan="6"/>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;&#x00A0;&#x00A0;A/A</td>
<td align="center" valign="top">88 (57.1&#x0025;)</td>
<td align="center" valign="top">56 (36.1&#x0025;)</td>
<td align="center" valign="top">0.001<sup><xref rid="tfn2-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">90 (59.2&#x0025;)</td>
<td align="center" valign="top">54 (35.8&#x0025;)</td>
<td align="center" valign="top">&#x003C;0.001<sup><xref rid="tfn2-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;&#x00A0;&#x00A0;A/G</td>
<td align="center" valign="top">49 (31.8&#x0025;)</td>
<td align="center" valign="top">65 (41.9&#x0025;)</td>
<td/>
<td align="center" valign="top">48 (31.6&#x0025;)</td>
<td align="center" valign="top">64 (42.4&#x0025;)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;&#x00A0;&#x00A0;G/G</td>
<td align="center" valign="top">17 (11.1&#x0025;)</td>
<td align="center" valign="top">34 (22.0&#x0025;)</td>
<td/>
<td align="center" valign="top">14 (9.2&#x0025;)</td>
<td align="center" valign="top">33 (21.8&#x0025;)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Allele</td>
<td colspan="6"/>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;&#x00A0;&#x00A0;A</td>
<td align="center" valign="top">225 (73.1&#x0025;)</td>
<td align="center" valign="top">177 (57.1&#x0025;)</td>
<td align="center" valign="top">&#x003C;0.001<sup><xref rid="tfn2-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">228 (75.0&#x0025;)</td>
<td align="center" valign="top">172 (57.0&#x0025;)</td>
<td align="center" valign="top">&#x003C;0.001<sup><xref rid="tfn2-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;&#x00A0;&#x00A0;G</td>
<td align="center" valign="top">83 (26.9&#x0025;)</td>
<td align="center" valign="top">133 (42.9&#x0025;)</td>
<td/>
<td align="center" valign="top">76 (25.0&#x0025;)</td>
<td align="center" valign="top">130 (43.0&#x0025;)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">rs1927911 (SNP2)</td>
<td colspan="6"/>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Genotype</td>
<td colspan="6"/>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;&#x00A0;&#x00A0;G/G</td>
<td align="center" valign="top">90 (58.4&#x0025;)</td>
<td align="center" valign="top">55 (35.5&#x0025;)</td>
<td align="center" valign="top">&#x003C;0.001<sup><xref rid="tfn2-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">91 (59.9&#x0025;)</td>
<td align="center" valign="top">55 (36.4&#x0025;)</td>
<td align="center" valign="top">&#x003C;0.001<sup><xref rid="tfn2-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;&#x00A0;&#x00A0;G/A</td>
<td align="center" valign="top">47 (30.5&#x0025;)</td>
<td align="center" valign="top">73 (47.1&#x0025;)</td>
<td/>
<td align="center" valign="top">45 (29.6&#x0025;)</td>
<td align="center" valign="top">70 (46.4&#x0025;)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;&#x00A0;&#x00A0;A/A</td>
<td align="center" valign="top">17 (11.1&#x0025;)</td>
<td align="center" valign="top">27 (17.4&#x0025;)</td>
<td/>
<td align="center" valign="top">16 (10.5&#x0025;)</td>
<td align="center" valign="top">26 (17.2&#x0025;)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Allele</td>
<td colspan="6"/>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;&#x00A0;&#x00A0;G</td>
<td align="center" valign="top">227 (73.7&#x0025;)</td>
<td align="center" valign="top">183 (59.0&#x0025;)</td>
<td align="center" valign="top">&#x003C;0.001<sup><xref rid="tfn2-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">227 (73.7&#x0025;)</td>
<td align="center" valign="top">180 (59.6&#x0025;)</td>
<td align="center" valign="top">&#x003C;0.001<sup><xref rid="tfn2-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;&#x00A0;&#x00A0;A</td>
<td align="center" valign="top">81 (26.3&#x0025;)</td>
<td align="center" valign="top">127 (41.0&#x0025;)</td>
<td/>
<td align="center" valign="top">81 (26.3&#x0025;)</td>
<td align="center" valign="top">122 (40.4&#x0025;)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">rs4986790 (SNP3)</td>
<td colspan="6"/>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Genotype</td>
<td colspan="6"/>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;&#x00A0;&#x00A0;A/A</td>
<td align="center" valign="top">142 (92.3&#x0025;)</td>
<td align="center" valign="top">152 (98.1&#x0025;)</td>
<td align="center" valign="top">0.015<sup><xref rid="tfn2-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">148 (97.4&#x0025;)</td>
<td align="center" valign="top">149 (98.7&#x0025;)</td>
<td align="center" valign="top">0.345</td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;&#x00A0;&#x00A0;A/G</td>
<td align="center" valign="top">12 (7.7&#x0025;)</td>
<td align="center" valign="top">3 (1.9&#x0025;)</td>
<td/>
<td align="center" valign="top">4 (2.6&#x0025;)</td>
<td align="center" valign="top">2 (1.3&#x0025;)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;&#x00A0;&#x00A0;G/G</td>
<td align="center" valign="top">0 (0.0&#x0025;)</td>
<td align="center" valign="top">0 (0.0&#x0025;)</td>
<td/>
<td align="center" valign="top">0 (0.0&#x0025;)</td>
<td align="center" valign="top">0 (0.0&#x0025;)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Allele</td>
<td colspan="6"/>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;&#x00A0;&#x00A0;A</td>
<td align="center" valign="top">296 (96.1&#x0025;)</td>
<td align="center" valign="top">307 (99.0&#x0025;)</td>
<td align="center" valign="top">0.016<sup><xref rid="tfn2-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">296 (98.7&#x0025;)</td>
<td align="center" valign="top">300 (99.3&#x0025;)</td>
<td align="center" valign="top">0.340</td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;&#x00A0;&#x00A0;G</td>
<td align="center" valign="top">12 (3.9&#x0025;)</td>
<td align="center" valign="top">3 (1.0&#x0025;)</td>
<td/>
<td align="center" valign="top">4 (1.3&#x0025;)</td>
<td align="center" valign="top">2 (0.7&#x0025;)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">rs4986791 (SNP4)</td>
<td colspan="6"/>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Genotype</td>
<td colspan="6"/>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;&#x00A0;&#x00A0;C/C</td>
<td align="center" valign="top">154 (100&#x0025;)</td>
<td align="center" valign="top">155 (100&#x0025;)</td>
<td align="center" valign="top">&#x2013;</td>
<td align="center" valign="top">152 (100&#x0025;)</td>
<td align="center" valign="top">151 (100&#x0025;)</td>
<td align="center" valign="top">&#x2013;</td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;&#x00A0;&#x00A0;C/T</td>
<td align="center" valign="top">0 (0&#x0025;)</td>
<td align="center" valign="top">0 (0&#x0025;)</td>
<td/>
<td align="center" valign="top">0 (0&#x0025;)</td>
<td align="center" valign="top">0 (0&#x0025;)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;&#x00A0;&#x00A0;T/T</td>
<td align="center" valign="top">0 (0&#x0025;)</td>
<td align="center" valign="top">0 (0&#x0025;)</td>
<td/>
<td align="center" valign="top">0 (0&#x0025;)</td>
<td align="center" valign="top">0 (0&#x0025;)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Allele</td>
<td colspan="6"/>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;&#x00A0;&#x00A0;C</td>
<td align="center" valign="top">308 (100&#x0025;)</td>
<td align="center" valign="top">310 (100&#x0025;)</td>
<td align="center" valign="top">&#x2013;</td>
<td align="center" valign="top">304 (100&#x0025;)</td>
<td align="center" valign="top">302 (100&#x0025;)</td>
<td align="center" valign="top">&#x2013;</td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;&#x00A0;&#x00A0;T</td>
<td align="center" valign="top">0 (0&#x0025;)</td>
<td align="center" valign="top">0 (0&#x0025;)</td>
<td/>
<td align="center" valign="top">0 (0&#x0025;)</td>
<td align="center" valign="top">0 (0&#x0025;)</td>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn2-etm-0-0-3796"><label>a</label><p>P&#x003C;0.05. P-values for genotype were calculated by Fisher&#x0027;s exact test. RSM, recurrent spontaneous miscarriage; SNP, single nucleotide polymorphism.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tIII-etm-0-0-3796" position="float">
<label>Table III.</label>
<caption><p>Odds ratios and 95&#x0025; confidence intervals for each risk factor and SNP associated with RSM in Uygur women.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th align="center" valign="bottom" colspan="3">Uygur</th>
</tr>
<tr>
<th/>
<th align="center" valign="bottom" colspan="3"><hr/></th>
</tr>
<tr>
<th align="left" valign="bottom">Risk factor</th>
<th align="center" valign="bottom">Odd ratios</th>
<th align="center" valign="bottom">95&#x0025; confidence interval</th>
<th align="center" valign="bottom">P-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">rs1927914 (SNP1)</td>
<td align="center" valign="top">6.86</td>
<td align="center" valign="top">1.934&#x2013;46.950</td>
<td align="center" valign="top">0.012<sup><xref rid="tfn3-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Menarche (years)</td>
<td align="center" valign="top">0.731</td>
<td align="center" valign="top">0.343&#x2013;1.524</td>
<td align="center" valign="top">0.419</td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Systolic blood pressure (mmHg)</td>
<td align="center" valign="top">1.135</td>
<td align="center" valign="top">1.029&#x2013;1.249</td>
<td align="center" valign="top">0.011<sup><xref rid="tfn3-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Diastolic blood pressure (mmHg)</td>
<td align="center" valign="top">1.046</td>
<td align="center" valign="top">1.017&#x2013;1.065</td>
<td align="center" valign="top">0.003<sup><xref rid="tfn3-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Spontaneous miscarriages</td>
<td align="center" valign="top">0.672</td>
<td align="center" valign="top">0.413&#x2013;1.089</td>
<td align="center" valign="top">0.121</td>
</tr>
<tr>
<td align="left" valign="top">rs1927911 (SNP2)</td>
<td align="center" valign="top">4.824</td>
<td align="center" valign="top">1.203&#x2013;19.672</td>
<td align="center" valign="top">0.024<sup><xref rid="tfn3-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Menarche (years)</td>
<td align="center" valign="top">1.771</td>
<td align="center" valign="top">1.070&#x2013;2.931</td>
<td align="center" valign="top">0.026<sup><xref rid="tfn3-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Systolic blood pressure (mmHg)</td>
<td align="center" valign="top">2.421</td>
<td align="center" valign="top">1.091&#x2013;5.297</td>
<td align="center" valign="top">0.021<sup><xref rid="tfn3-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Diastolic blood pressure (mmHg)</td>
<td align="center" valign="top">0.673</td>
<td align="center" valign="top">0.383&#x2013;1.182</td>
<td align="center" valign="top">0.172</td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Spontaneous miscarriages</td>
<td align="center" valign="top">0.616</td>
<td align="center" valign="top">0.225&#x2013;1.683</td>
<td align="center" valign="top">0.345</td>
</tr>
<tr>
<td align="left" valign="top">rs4986790 (SNP3)</td>
<td align="center" valign="top">8.272</td>
<td align="center" valign="top">1.168&#x2013;40.358</td>
<td align="center" valign="top">0.035<sup><xref rid="tfn3-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Menarche (years)</td>
<td align="center" valign="top">1.121</td>
<td align="center" valign="top">0.351&#x2013;3.562</td>
<td align="center" valign="top">0.852</td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Systolic blood pressure (mmHg)</td>
<td align="center" valign="top">2.487</td>
<td align="center" valign="top">1.089&#x2013;5.745</td>
<td align="center" valign="top">0.032<sup><xref rid="tfn3-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Diastolic blood pressure (mmHg)</td>
<td align="center" valign="top">1.405</td>
<td align="center" valign="top">0.648&#x2013;3.031</td>
<td align="center" valign="top">0.386</td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Spontaneous miscarriages</td>
<td align="center" valign="top">2.619</td>
<td align="center" valign="top">1.006&#x2013;6.811</td>
<td align="center" valign="top">0.047<sup><xref rid="tfn3-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn3-etm-0-0-3796"><label>a</label><p>P&#x003C;0.05. RSM, recurrent spontaneous miscarriage; SNP, single nucleotide polymorphism.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tIV-etm-0-0-3796" position="float">
<label>Table IV.</label>
<caption><p>Odds ratios and 95&#x0025; confidence intervals for each risk factor and SNP associated with RSM in Han women.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th align="center" valign="bottom" colspan="3">Han</th>
</tr>
<tr>
<th/>
<th align="center" valign="bottom" colspan="3"><hr/></th>
</tr>
<tr>
<th align="left" valign="bottom">Risk factor</th>
<th align="center" valign="bottom">Odd ratios</th>
<th align="center" valign="bottom">95&#x0025; confidence interval</th>
<th align="center" valign="bottom">P-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">rs1927914 (SNP1)</td>
<td align="center" valign="top">6.431</td>
<td align="center" valign="top">1.321&#x2013;31.347</td>
<td align="center" valign="top">0.021<sup><xref rid="tfn4-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Systolic blood pressure (mmHg)</td>
<td align="center" valign="top">1.967</td>
<td align="center" valign="top">1.071&#x2013;3.589</td>
<td align="center" valign="top">0.037<sup><xref rid="tfn4-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Number of pregnancies</td>
<td align="center" valign="top">1.185</td>
<td align="center" valign="top">0.597&#x2013;2.358</td>
<td align="center" valign="top">0.634</td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Spontaneous miscarriages</td>
<td align="center" valign="top">0.412</td>
<td align="center" valign="top">0.113&#x2013;1.514</td>
<td align="center" valign="top">0.186</td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Drinking (&#x0025;)</td>
<td align="center" valign="top">1.579</td>
<td align="center" valign="top">0.807&#x2013;3.076</td>
<td align="center" valign="top">0.183</td>
</tr>
<tr>
<td align="left" valign="top">rs1927911 (SNP2)</td>
<td align="center" valign="top">2.234</td>
<td align="center" valign="top">1.271&#x2013;3.917</td>
<td align="center" valign="top">0.004<sup><xref rid="tfn4-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Systolic blood pressure (mmHg)</td>
<td align="center" valign="top">1.127</td>
<td align="center" valign="top">1.029&#x2013;1.235</td>
<td align="center" valign="top">0.008<sup><xref rid="tfn4-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Number of pregnancies</td>
<td align="center" valign="top">1.156</td>
<td align="center" valign="top">0.933&#x2013;1.435</td>
<td align="center" valign="top">0.187</td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Spontaneous miscarriages</td>
<td align="center" valign="top">1.046</td>
<td align="center" valign="top">1.022&#x2013;1.074</td>
<td align="center" valign="top">0.001<sup><xref rid="tfn4-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Drinking (&#x0025;)</td>
<td align="center" valign="top">1.970</td>
<td align="center" valign="top">0.632&#x2013;6.145</td>
<td align="center" valign="top">0.249</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn4-etm-0-0-3796"><label>a</label><p>P&#x003C;0.05. RSM, recurrent spontaneous miscarriage; SNP, single nucleotide polymorphism.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tV-etm-0-0-3796" position="float">
<label>Table V.</label>
<caption><p>Haplotype analysis in RSM patients and controls.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th align="center" valign="bottom" colspan="3">Haplotype</th>
<th align="center" valign="bottom" colspan="2">Frequency in Uygur</th>
<th/>
<th align="center" valign="bottom" colspan="2">Frequency in Han</th>
<th/>
</tr>
<tr>
<th/>
<th align="center" valign="bottom" colspan="3"><hr/></th>
<th align="center" valign="bottom" colspan="2"><hr/></th>
<th/>
<th align="center" valign="bottom" colspan="2"><hr/></th>
<th/>
</tr>
<tr>
<th align="left" valign="bottom">No.</th>
<th align="center" valign="bottom">SNP1</th>
<th align="center" valign="bottom">SNP2</th>
<th align="center" valign="bottom">SNP3</th>
<th align="center" valign="bottom">RSM patients</th>
<th align="center" valign="bottom">Controls</th>
<th align="center" valign="bottom">P-value</th>
<th align="center" valign="bottom">RSM patients</th>
<th align="center" valign="bottom">Controls</th>
<th align="center" valign="bottom">P-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">H1</td>
<td align="center" valign="top">G</td>
<td align="center" valign="top">A</td>
<td align="center" valign="top">A</td>
<td align="center" valign="top">0.164</td>
<td align="center" valign="top">0.236</td>
<td align="center" valign="top">0.756</td>
<td align="center" valign="top">0.177</td>
<td align="center" valign="top">0.282</td>
<td align="center" valign="top">0.412</td>
</tr>
<tr>
<td align="left" valign="top">H2</td>
<td align="center" valign="top">G</td>
<td align="center" valign="top">G</td>
<td align="center" valign="top">A</td>
<td align="center" valign="top">0.086</td>
<td align="center" valign="top">0.187</td>
<td align="center" valign="top">0.298</td>
<td align="center" valign="top">0.067</td>
<td align="center" valign="top">0.145</td>
<td align="center" valign="top">0.398</td>
</tr>
<tr>
<td align="left" valign="top">H3</td>
<td align="center" valign="top">G</td>
<td align="center" valign="top">G</td>
<td align="center" valign="top">G</td>
<td align="center" valign="top">0.019</td>
<td align="center" valign="top">0.006</td>
<td align="center" valign="top">0.540</td>
<td align="center" valign="top">0.006</td>
<td align="center" valign="top">0.003</td>
<td align="center" valign="top">0.158</td>
</tr>
<tr>
<td align="left" valign="top">H4</td>
<td align="center" valign="top">A</td>
<td align="center" valign="top">A</td>
<td align="center" valign="top">A</td>
<td align="center" valign="top">0.099</td>
<td align="center" valign="top">0.174</td>
<td align="center" valign="top">0.389</td>
<td align="center" valign="top">0.086</td>
<td align="center" valign="top">0.122</td>
<td align="center" valign="top">0.415</td>
</tr>
<tr>
<td align="left" valign="top">H5</td>
<td align="center" valign="top">A</td>
<td align="center" valign="top">G</td>
<td align="center" valign="top">A</td>
<td align="center" valign="top">0.632</td>
<td align="center" valign="top">0.393</td>
<td align="center" valign="top">0.633</td>
<td align="center" valign="top">0.658</td>
<td align="center" valign="top">0.445</td>
<td align="center" valign="top">0.406</td>
</tr>
<tr>
<td align="left" valign="top">H6</td>
<td align="center" valign="top">A</td>
<td align="center" valign="top">G</td>
<td align="center" valign="top">G</td>
<td align="center" valign="top">0.020</td>
<td align="center" valign="top">0.004</td>
<td align="center" valign="top">0.016<sup><xref rid="tfn5-etm-0-0-3796" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">0.006</td>
<td align="center" valign="top">0.003</td>
<td align="center" valign="top">0.137</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn5-etm-0-0-3796"><label>a</label><p>P&#x003C;0.05. Haplotypes were estimated using SNPAlyze software. P-values were calculated by the permutation test. RSM, recurrent spontaneous miscarriage; SNP, single nucleotide polymorphism.</p></fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>
